Segmentron Viewer
by Dgnct LLC
510(k) K251072
Segmentron Viewer is a medical device (FDA Class II; FDA product code QIH, Automated Radiological Image Processing Software) made by Dgnct LLC, cleared under FDA 510(k) K251072 on 9 Sep 2025, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK251072 | Date9 Sep 2025 | StatusActive |
Official records
- FDA 510(k) database K251072
From the FDA record
- Received by the FDA
- 7 Apr 2025
- FDA decision
- 9 Sep 2025 (Substantially Equivalent)
- FDA review time
- 155 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- QIH
- FDA applicant
- DGNCT, LLC
- Device class
- Class II
- Regulation
- 21 CFR Part 892.2050
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Devices cleared under K251072
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| Segmentron Viewer 1.0 | 1.0 | 00860010268087 | — | On the market |
Similar devices
Other devices filed under FDA product code QIH (Automated Radiological Image Processing Software).
- uSONIQUE uSONIQUE Grace Elite by Wuhan United Imaging Healthcare Co., Ltd.
- Synapse PACS 7.5 by FUJIFILM Healthcare Americas Corporation
- IRISeg by Intuitive Surgical, Inc.
- AiORTA - Plan v2.0 by Vitaa Medical Solutions Inc.
- Adravision Perio by Adra Corporation
- DS Core CBCT Anatomy 04262352350059 S3816 by Zetta25 AG
- MediAI-OA by Crescom Co., Ltd.
- AI Platform 2.0 (AIP002) by Exo Imaging
- B-Right Views Fetal Heart V1.x by Brightheart
- Preview Shoulder by GENESIS SOFTWARE INNOVATIONS